Intravesical instillation of chemotherapeutic agents is expected to be a valuable tool for the treatment of bladder carcinoma, for the cancerous tissues could be directly exposed to higher concentration of the agents with less toxicity as compared with systemic administration of the agents. A variety of agents have been employed topically and there is suggestion that some of the compounds lead to clinically beneficial effect on this disease (Bateman 1955 Mishina et al. 1975 ). Veenema (1968) reviewed his results in over 100 patients with bladder carcinoma who were submitted to intravesical instillation of triethylene thiophosphoramide (Thio-Tepa) and stated that this therapy produced objective remission and even complete disappearances of superficial bladder tumors. One-third of his patients had complete tumor disappearance, one-third had partial regression and the remaining third had no effect. Since his report this polyfunctional alkylating agent has been widely used for topical chemotherapy of bladder carcinoma and general agreement with the clinical usefulness of Thio Tepa is established (Jones and Swinney 1961; Wescott 1966; Veenema et al. 1969 ).
There are, however, still many questions to be answered about the use of Thio Tepa for local treatment of bladder carcinoma. The urologist has no definite idea as to whether Thio-Tepa could produce permanent cure or what the most effective dose schedule is. Although Thio-Tepa instillation is best reserved for the urologist at present as an adjunct to surgical treatment for bladder carcinoma, specific information as to the effect of this compound on the bladder carcinoma cell itself is insufficient. In view of increasing topical use of various chernother apeutic agents for bladder carcinoma, an experimental study of the effect of Thio Tepa on cell kinetics was conducted. In the present work an established cell line of human bladder carcinoma was employed as an in vitro model. When the cell cycle immediately after Thio-Tepa administration was concerned, 3H-TdR was added 30 min before removal of the drug into the Petri dish in which the cover slips had been placed with the drug, so that both the drug and the precursor were washed off at the same time.
MATERIALS AND METHODS

RESULTS
Cytotoxic effect of Thio-Tepa. 30% as compared with the control. S phase is elongated by 46% of the control and G1 phase is less effected than S phase, while alteration of G2 phase is much less than those of the former two phases.
As seen in Fig. 1 regrowth of the cells takes place within 2 days after the treatment with static dose of Thio-Tepa, being assumed that the cell cycle should he changed again. Cell cycle analysis was performed 48 hr following the treatment, when the cells were on day 5 of culture. The FLM curve of the treated cells, which is illustrated with a dotted line in Fig. 4 , becomes nearly close to that of the control. Analysis of cell cycle parameters summarized in Table 2 confirms this observation; that is, Tc, TS and TG1 of the treated cells are rather shorter than those of the control, whereas TG2 remains unchanged.
What is interesting is that Tc of the untreated cells on day 5 decreases to 21.9 hr which is clearly shorter than the value of 26.2 hr on day 3. Reduction of Tc is calculated, to he attributed to decrease of S and GI phase durations as present ed in Table 2 . 
